BPIfrance’s Large Venture fund and Mubadala Capital added $18m to the medical data research platform's GV-backed series A round.

Existing backer Legend Capital contributed to an eight-figure dollar round for the Tsinghua-backed chemistry services provider.

The beauty and cosmetics group is acquiring a 20% stake in Kim Kardashian West's beauty brand at a $1bn valuation in connection with a partnership agreement.

Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.

Sinopec Capital and Meinian Onehealth both invested in the biotech research product maker as it prepares for an initial public offering.

Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.

Index Ventures participated in a round that valued the WarnerMedia and Tencent-backed communication platform developer at $3.5bn.

Samsung Catalyst Fund, BBVA, SBI Group and ABN Amro Ventures chipped in as the banking platform developer raised $67.3m at a $360m valuation.

Rabobank was among the investors as the crop protection technology developer publicly launched having raised a total of $66m since inception.

The smart parking technology developer has received $42.4m of fresh capital which came two years after a series B round led by Nio Capital.